{"SPADE_UN_25869": {"Sequence Information": {"Peptide Name": "Tasidotin", "Sequence": "XVXPP", "Sequence Length": 5, "Biological Activity": ["Anticancer"], "Binding Target": "1. Mitochondrial membrane", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Preclinical analysis of tasidotin HCl in Ewing's sarcoma, rhabdomyosarcoma, synovial sarcoma, and osteosarcoma.", "Pubmed ID": "17875774", "Reference": "Clin Cancer Res. 2007;13:5446-5454", "Author": "Garg V, Zhang W, Gidwani P, Kim M, Kolb EA", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/17875774"}], "SPADE ID": "SPADE_UN_25869", "Similar Sequences": [{"SPADE_ID": "SPADE_N_00235", "Similarity": 1.0, "Sequence": "YSYKKIDCGGACAARCRLSSRPRLCNRACGTCCARCNCVPPGTSGNTETCPCYASLTTHGNKRKCP"}, {"SPADE_ID": "SPADE_N_00265", "Similarity": 1.0, "Sequence": "EQCGNQAGGVPPNG"}, {"SPADE_ID": "SPADE_N_00472", "Similarity": 1.0, "Sequence": "YDLFTGIGIDARTVPPTCYESCNATFQNPECNKMCVGLAYKDGSCIYPPPEVDGLPPKRPYFPRCCCNPIILSPPSP"}], "Hemolytic Activity": "", "Target Organism": "Human rhabdomyosarcoma RH30(IC50=0.02µM),Human rhabdomyosarcoma RD(IC50=0.02µM),Ewing’s Sarcoma SK-ES1(IC50=0.25µM),Ewing’s Sarcoma SK-PN-DW(IC50=0.13µM),Synovial Sarcoma HSSY-II(IC50=0.26µM),Synovial Sarcoma SYO-1(IC50=0.32µM),Human osteosarcoma SaOS(IC50=0.002µM)"}}}